Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis

Clinical trial NCT06915766 · AVAILABLE

Trial details

NCT number: NCT06915766
Sponsor: Cogent Biosciences, Inc.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Systemic Mastocytoses, Indolent Systemic Mastocytoses, Aggressive

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.